Nova Tina Susan — SEC insider filings

SEC reporting owner CIK 1302605. 17 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-08-28 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARENA PHARMACEUTICALS INC (ARNA)Director3—1 leg · 17,300 sh · $1,175,30316
EXAGEN INC. (XGN)Director6——6
Azenta, Inc. (AZTA)Director4——4
VERACYTE, INC. (VCYT)President, CLIA U.S.2——3
Aurinia Pharmaceuticals Inc. (AUPH)Director2——2

Insider filings — Nova Tina Susan

FiledFormIssuerReported transactionsSource
2026-11-024EXAGEN INC. (XGN)Grant/award (A): 56,200 (derivative) @ $0EDGAR
2026-06-084Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 23,931 (derivative) @ $0EDGAR
2026-02-064Azenta, Inc. (AZTA)Grant/award (A): 5,663 @ $27.85EDGAR
2025-06-124EXAGEN INC. (XGN)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2025-05-164Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 63,724 (derivative) @ $0EDGAR
2025-02-114Azenta, Inc. (AZTA)Grant/award (A): 4,040 @ $52.32EDGAR
2024-06-124EXAGEN INC. (XGN)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2024-02-134Azenta, Inc. (AZTA)Grant/award (A): 2,465 @ $65.93EDGAR
2023-06-204EXAGEN INC. (XGN)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2023-02-154Azenta, Inc. (AZTA)Grant/award (A): 3,604 @ $0EDGAR
2022-06-214EXAGEN INC. (XGN)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2022-03-114ARENA PHARMACEUTICALS INC (ARNA)Other (J): 17,776 · Other (J): 3,067 · Disposition to issuer (D): 4,800 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2022-03-074VERACYTE, INC. (VCYT)Grant/award (A): 56,546 @ $0 · Grant/award (A): 103,043 (derivative) @ $0EDGAR
2022-03-044VERACYTE, INC. (VCYT)Tax withholding (F): 10,695 @ $27.84EDGAR
2021-06-214EXAGEN INC. (XGN)Grant/award (A): 9,000 (derivative) @ $0EDGAR
2021-06-154ARENA PHARMACEUTICALS INC (ARNA)Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR
2020-08-284ARENA PHARMACEUTICALS INC (ARNA)Option exercise (M): 1,200 @ $14.90 · Option exercise (M): 3,600 @ $12.70 · Option exercise (M): 12,500 @ $20 · Sale (S): 17,300 @ $67.94 · Option exercise (M): 1,200 (derivative) @ $0 · Option exercise (M): 3,600 (derivative) @ $0 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1302605 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs